Liên hệ chúng tôi
Về công ty
CardioMech is a developer of therapeutic devices for structural heart disease that provides a transcatheter alternative to cardiac surgery for the placement of artificial chords for the mitral valve. The company's devices are used for the placement of artificial chords, enabling surgeons to get access to new therapeutic options for heart diseases. The technology is being developed to treat patients with severe, symptomatic, degenerative mitral regurgitation (DMR) due to prolapse or flail. CardioMech was founded in 2015 and is headquartered in Trondheim, Norway.
NO
Không xác định
Chưa xác minh công ty
Minh bạch kinh doanh
- Chưa xác minh thông tin công ty
- Yêu cầu khách hàng của họ đánh giá
- Không trả lời các đánh giá tiêu cực